Open AccessPrognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation
Author(s) -
Mehmet Kadri Akboğa,
Samet Yılmaz,
Rıdvan Yalçın
Publication year - 2021
Publication title -
pubmed central
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.364
H-Index - 28
eISSN - 2149-2271
DOI - 10.5152/anatoljcardiol.2021.03982
Subject(s) - medicine , atrial fibrillation , cardiology , cha2ds2–vasc score , heart failure , hazard ratio , myocardial infarction , ejection fraction , stroke (engine) , odds ratio , percutaneous coronary intervention , confidence interval , acute coronary syndrome , ischemic stroke , ischemia , mechanical engineering , engineering
To evaluate the prognostic value of preprocedural CHA2DS2-VASc [congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, previous stroke or transient ischemic attack (TIA) (doubled), vascular disease, age 65-74 years, female gender] score in predicting high SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score and in-hospital mortality for non-atrial fibrillation (AF) patients presenting with non-ST elevation myocardial infarction (NSTEMI). The CHA2DS2-VASc score used to determine thromboembolic risks in AF was recently reported to predict major adverse clinical outcomes in patients with the acute coronary syndrome, irrespective of AF.